VIATRIS INC. Debt Instrument, Face Amount
VIATRIS INC. (VTRS) had Debt Instrument, Face Amount of $11.64 billion as of 2020-09-27, per its 10-Q filed 2020-11-10.
Discontinued › Notes › Debt
us-gaap:DebtInstrumentFaceAmount · last filed 2020-11-10
- 2020-09-27: Debt Instrument, Face Amount $11.64B.
- 2020-06-28: Debt Instrument, Face Amount $11.49B.
| Period end | Debt Instrument, Face Amount |
|---|---|
| 2020-09-27 | $11.64B 10-Q · filed 2020-11-10 |
| 2020-06-28 | $11.49B 10-Q · filed 2020-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |